IDH Results Presentation

June 2021

Contents:

  • IDH At a Glance
  • 1Q 2021 Results Overview
  • Key Investment Highlights
    • Our Market
    • Our Business Model
    • Financial Position and Performance
    • Growth Strategies
    • Governance

Who We Are

Integrated Diagnostics Holding is a leading, fully-integrated provider of high-quality medical

diagnostic services with a footprint spanning Egypt, Jordan, Sudan and Nigeria

Our Services

Our Brands

Accreditations

Immunology Radiology Hematology

Endocrinology

Clinical

Molecular

Chemistry

Biology

Cytogenetics Histopathology Microbiology

+ 40 years

7 key brands

483

27.1 MN

Hena Holdings

Track record

With strong awareness

Branch labs as at 31 Mar. 2021

FY20 Tests

21%

EGP 2.7BN

Shareholding 54%

Ltd

+2,000

4

7.1 MN

Actis Idn B.V.

Structure

Free Float

Diagnostic tests

Country footprint (Egypt,

FY20 Patients

FY20 Revenues

Jordan, Sudan & Nigeria)

offered

26%

3 INTEGRATED DIAGNOSTICS HOLDINGS

Our Geography

IDH's branch network of 483 labs as at 31 March 2021 spans 4 countries, the largest of which is

Egypt

20

The Company's Egyptian

operations contributed

branches

82% of consolidated

revenues in 1Q 2021

Jordan

431

EGYPT

Branches

Egypt

81.5%

1979

Cairo Region

1Q 2021

49%

Upper Egypt Region

16%

JORDAN

Alexandria Region

Sudan

16.8%

2011

1Q 2021

9%

Delta Region

Nigeria

26%

SUDAN

0.6%

2011

12

1Q 2021

branches

20

NIGERIA

branches

1.1%

2018

1Q 2021

4 INTEGRATED DIAGNOSTICS HOLDINGS

Our Patients

IDH serves two principal types of patients: contract and walk-in

Around 70% of total revenue generated across the two segments is paid in cash

Contract Patients

Walk-In Patients

IDH's contract clients include institutions who enter into one-year renewable contracts at agreed rates per-testand on a per-clientbasis. Around 40% of the revenue generated by the segment is paid in cash. IDH's corporate clients roster currently features institutions such as:

  • Unions

IDH's walk-in clients, also referred to as "self-payers",pay out of pocket for diagnostic tests and other services.

  • Syndicates
  • Private and public insurance companies
  • Banks and corporations
  • Public institutions

Contribution to IDH Revenue (1Q 2021)

EGP

47% 1,130 53%

mn

Patient Split by Segment (1Q 2021)

34%

2.4 mn

patients

66%

Contract Revenues

Walk-in Revenues

Contract Patients

Walk-in Patients

5 INTEGRATED DIAGNOSTICS HOLDINGS

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original document
  • Permalink

Disclaimer

IDH - Integrated Diagnostics Holdings plc published this content on 14 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 June 2021 09:32:01 UTC.